BioXcel Therapeutics (NASDAQ: BTAI)
BioXcel Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
BioXcel Therapeutics Company Info
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in developing artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology. It also focuses on utilizing cutting-edge technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
News & Analysis
Why Shares of BioXcel Therapeutics Fell This Week
The company's co-founder is leaving, and layoffs are coming.
Why BioXcel Therapeutics Stock Flopped Again Today
Major changes are afoot with the company, and few are happy about them.
Why BioXcel Therapeutics Stock Is Getting Crushed Today
BioXcel just announced a big change.
Why BioXcel Therapeutics Stock Was Bouncing Back This Week
What a difference a handful of trading days has made for the company.
Why Shares of BioXcel Therapeutics Are Plunging Thursday
Questions regarding the safety of an Alzheimer's disease agitation therapy were raised when the company announced phase 3 trial results.
Why Shares of BioXcel Therapeutics Are Dropping Thursday
A trial for one of the company's therapies didn't meet its primary end point.
Why BioXcel Therapeutics Stock Marched Higher Today
The biotech's Q1 earnings report set the stage for a flurry of important clinical updates in the coming months.
Why BioXCel Therapeutics Stock Jumped This Week
Analysts boosted their price targets for the biotech stock.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.